Engineered molecules designed to bring T cells into close contact with tumor cells, triggering the immune system to destroy the cancer cells while sparing non-malignant cells.

Off-the-shelf treatments that use cancer-specific markers to target and destroy tumor cells based on their genetic mutations and patient immune type.